(Q41484699)

1 October 2017

1 reference

title

Methotrexate for psoriasis (English)

1 reference

1 October 2017

1 reference

2

Chalmers RJ

1 reference

1 October 2017

Boffa MJ

1

1 reference

1 October 2017

publication date

1 November 1996

1 reference

Clinical and Experimental Dermatology

1 October 2017

published in

1 reference

1 October 2017

volume

21

1 reference

1 October 2017

issue

6

1 reference

1 October 2017

page(s)

399-408

1 reference

Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1996.TB00142.X

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1996.TB00142.X

Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1996.TB00142.X

Acute renal failure due to concomitant action of methotrexate and indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1996.TB00142.X

Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1996.TB00142.X

Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1996.TB00142.X

Synergistic carcinogenic potential of methotrexate and PUVA in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.1996.TB00142.X

10.1111/J.1365-2230.1996.TB00142.X

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference